After a rocky start to the spring, Wall Street came roaring back in May. President Trump’s softened tariff stance reignited ...

Fintel reports that on June 3, 2025, Oppenheimer initiated coverage of Axsome Therapeutics (NasdaqGM:AXSM) with a Outperform ...

Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an ...

Chipmaker Broadcom is set to report quarterly results after the closing bell Thursday, with Wall Street analysts expecting ...

Peter Oppenheimer, chief global equity strategist at Goldman Sachs, says the prospect of looser monetary and fiscal policy in ...

Discover which Christopher Nolan blockbuster tops the list as his most expensive production, reaching a quarter of a billion ...

Long before blockbusters like Oppenheimer and Interstellar, Christopher Nolan directed this brilliant but overlooked thriller ...

Oppenheimer analyst Christopher Glynn upped Nordson Corporation (NASDAQ:NDSN)’s stock from “Perform” to “Outperform” with a ...

All told, Oppenheimer analyst Rick Schafer feels good about Nvidia's positioning coming out of earnings. "The best house on the best block, \[Nvidia\] remains arguably best positioned in AI, ...

Little is known about the currently untitled film yet, other than the fact that Chazelle, who is perhaps best known for ...